
 Mankind Pharma Limited IPO - Price, Lot size, Open date, GMP & Review - Online Demat, Trading, and Mutual Fund Investment in India - Fisdom                Skip to content          Products    Stocks      IPOs & more      Mutual Funds       Pension Funds  Private Wealth Resources    Research      One Percent Academy      Blogs      Calculators   Company    About us      Careers      Contact us   LoginDownload app   Blog    Stock MarketsStock Markets                             Mankind Pharma Limited IPO – Price, Lot size, Open date, GMP & Review RudriRawellWritten by - Rudri RawellApril 22, 2023  6 minutes  The stock market in India has been experiencing a turbulent start to 2023, with only a few companies coming up with their IPOs. However, for investors who are looking for new investment opportunities, Mankind Pharma Ltd IPO seems like a glimmer of hope. As one of the leading pharmaceutical companies in India, Mankind Pharma has been delivering quality products and services for over 25 years. With a strong focus on research and development, the company has been expanding its product portfolio and footprint globally. This blog will provide an in-depth analysis of Mankind Pharma Ltd IPO and its potential for investors looking to invest in the pharmaceutical sector.Mankind Pharma Limited IPO will open for subscription on 25th April 2023 and will close on 27th April 2023.Here are all the essential details of Mankind Pharma Limited IPO, including investment price band, allotment date, GMP, benefits, risks of investing in this IPO, and more.  Table of Contents  hide   1 IPO Details   2 Mankind Pharma Limited IPO Objectives   3 Top things to know about Mankind Pharma Limited IPO   4 Financials of the company   5 Strengths of the company   6 Risks of investment   7 What is the Grey Market Premium (GMP) of Mankind Pharma Limited IPO?   8 Should you apply for Mankind Pharma Limited IPO?   9 How to apply for Mankind Pharma Limited IPO?   10 Mankind Pharma Limited IPO FAQs   11 Also read.. IPO Details The key details of the Mankind Pharma Limited IPO are as under. IPO Size The size of the IPO and different categories of the issue are:CategoryDetailsIPO Opening Date25th April 2023 IPO Closing Date27th April 2023ListingNSE, BSEIssue TypeBook Built Issue IPOFace Value of sharesRe. 1 per shareIPO Price BandRs. 1026 – Rs. 1080 per shareIPO SizeRs. 4,326 crores (40,058,844 shares)Offer For SaleRs. 4,326 crores (40,058,844 shares)Fresh IssueNilIPO Dates The important dates for the Mankind Pharma Limited IPO are highlighted below:EventDateOpening date25th April 2023Closing Date27th April 2023Allotment date3rd May 2023Refund Date4th May 2023Share Credit Date5th May 2023Listing Date8th May 2023IPO Lot Sizes Investors can subscribe to the shares of Mankind Pharma Limited IPO  in pre-defined lots. The details of the lot sizes for this IPO are mentioned below: CategoryDetailsInvestments in lots (for retail investors)Minimum – 1 lotMaximum – 14 lotsInvestment amount (for retail investors)Minimum – Rs. 14,040Maximum – Rs. 1,96,560Shares (HNI)Minimum – 15Maximum – 71IPO ReservationThe categories of eligible investors and their share in the IPO are tabled below:Category of InvestorReservation PercentageQIB (Qualified Institutional Buyers)50%NII (Non-Institutional Bidders)15%RII (Retail Individual Investors)35%Mankind Pharma Limited IPO ObjectivesThis IPO is an entirely Offer for Sale issue, which means that existing promoters of Mankind Pharma Ltd plan to offload some of their stake in the company. The company will not receive any proceeds from the offer and all the offer proceeds will be received by the selling shareholders.Top things to know about Mankind Pharma Limited IPOEstablished in 1991, Mankind Pharma Limited is a leading pharmaceutical company that specializes in developing, manufacturing, and distributing pharmaceutical formulations across a range of acute and chronic therapeutic areas, as well as consumer healthcare products.The company has a significant presence in the Indian market, catering to various therapeutic fields, such as anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. It boasts an impressive portfolio of over 36 brands, which includes popular names like Manforce (Rx), Moxikind-CV, Amlokind-AT, Unwanted-Kit, Candiforce, and Glimestar-M.Mankind Pharma has a vast distribution network of medical representatives in the Indian pharmaceutical market, which is one of the largest in the industry. More than 80% of doctors in India prescribe their formulations, making it one of the most trusted and reliable names in the field. In fact, the company was ranked 4th in terms of domestic sales during the Financial Year 2022, a testament to its success and growth.Financials of the companyMankind Pharma Limited financials are given in the table below:Year Total Assets (Rs. In crores)Operating Revenue (Rs. In crores)Profit after tax (Rs. In crores)Basic EPS(Rs.)Diluted EPS(Rs.)RONW(%)Mar-20229,1487,7811,45335.7835.7823.29Mar-20216,3736,2141,29331.5931.5926.80Mar-20205,0735,8651,05625.7225.7229.56(Source: RHP)Strengths of the companySome of the key strengths of Mankind Pharma Limited that investors can take note of are:CategoryDetailsBusiness model Mankind Pharma Limited has established itself as a leading domestic pharmaceutical company, with significant potential for further growth.The company has a strong presence in the consumer healthcare sector, which is continuously growing and has high brand recall among customers.The company has successfully leveraged its corporate brand to build and scale its brands, resulting in a diverse portfolio with strong rankings across key therapeutic areas.Mankind Pharma has a wide market and distribution coverage, with a focus on providing affordable and accessible healthcare solutions.Faster growthMankind Pharma has been able to outpace the Indian Pharmaceutical Market (IPM) with its volume-led growth strategy.Risks of investmentHere are some of the risks that investors of Mankind Pharma Limited IPO should know:CategoryDetailsBusiness viability and profitabilityThe company may face challenges in obtaining and maintaining intellectual property rights for its brands, which could lead to increased competition and decreased profitability. Additionally, protecting proprietary information may be difficult.Dependence on subsidiaries exposes the company to significant risks. Any financial or operational issues within these subsidiaries could adversely affect the company’s overall performance.Political, economic, or other factors beyond the company’s control may have an adverse effect on its business and results of operations. Uncertainties surrounding regulatory changes, government policies, and global events could lead to increased volatility and risk.Delays or defaults in customer payments and receivables could adversely impact profits and affect cash flows. This risk is particularly relevant in a highly competitive market with multiple players vying for business.CompetitionDue to the fragmented nature of the industry segments in which the company operates, it faces competition from other large and small players. Business interruption risks may arise from internal and external factors, which could impact operations.What is the Grey Market Premium (GMP) of Mankind Pharma Limited IPO?As of April 20th, 2023, the grey market premium for the shares of Mankind Pharma Limited is approximately between Rs. 74-82 as per market observers.Should you apply for Mankind Pharma Limited IPO?Mankind Pharma has over 36 brands in its portfolio and one of the largest distribution networks of medical representatives in the Indian pharmaceutical market, with over 80% of doctors prescribing their formulations. This IPO presents an opportunity for investors looking to gain exposure to the Indian healthcare industry.How to apply for Mankind Pharma Limited IPO?Investors can invest in this IPO through the Fisdom app.Mankind Pharma Limited IPO FAQs1. Which are the popular brand offerings of Mankind Pharma Ltd?Mankind Pharma Ltd owns some of the popular brands like ‘Manforce’ condoms, pregnancy test kit Prega News, emergency contraceptive brand Unwanted-72 and antacid powders (Gas-O-Fast) among others.2. Which companies are the competitors of Mankind Pharma Ltd?Some of Mankind Pharma’s competitors include Cipla Ltd, Sun Pharma, Zydus Lifesciences, Alkem Laboratories, and JB Chemicals & Pharmaceuticals.3. What is the GMP of Mankind Pharma Limited?The GMP of Mankind Pharma Limited as on 20th April 2023 ranged between approximately Rs. 74-82 per share.4. Do I need a Demat account to apply for Mankind Pharma Ltd IPO?Yes, to apply for any IPO, you need to have a Demat account. To open a Demat account today, you can download the Fisdom app on your smartphone.Also read..Favorite Sectors of Mutual Funds in Oct 2022Sectoral Mutual Funds | 5 Best Sector Funds for 2022Share the article                      Get exclusive content
 and expert adviceSubscribe to fisdom to get regular updates in the finance world delivered to your inbox each month   Subscribe Fisdom Story Popular CalculatorsCAGR Calculator 2023Compound Interest CalculatorFD CalculatorGratuity Calculator – Simple Gratuity Calculation Online 2023HRA CalculatorFree Online Tax Calculator for 2023-24 for Income Tax Slabs, – New vs Old RegimeLumpsum CalculatorFisdom NPS Calculator: Best free online tool for pension & annuity planning in IndiaEmployee Provident Fund (EPF) Calculator OnlineOnline PPF Calculator 2023-24 – Calculate return for your PPF Account at current interest rateRD CalculatorRetirement CalculatorSIP CalculatorStep Up SIP Calculator – Invest in Mutual FundsSWP Calculator: Best Online Tool for mutual fund Systematic Withdrawal Plan & Tax-efficient monthly income in IndiaBudget 2023 Highlights: PDF Download, Key Takeaways, Important Points Popular articles  Large Cap Stocks – What is it, Features & Factors to be Considered   Top Stocks Under Rs. 100 to Invest in 2023   Beta in Indian stocks – Types, Should you invest in high beta stocks?   Related Articles   Stock Markets  Large Cap Stocks – What is it, Features & Factors to be Considered 08 Jun  9 minutes   Stock Markets  Beta in Indian stocks – Types, Should you invest in high beta stocks? 07 Jun  8 minutes   Stock Markets  Top SIX Online Stock Market Courses in India-2023 05 Jun  8 minutes   FeaturedStock Markets  IKIO Lighting Limited IPO – Price, Lot size, Open date, GMP & Review 05 Jun  6 minutes   Stock Markets  Types of Earnings Per Share(EPS) – Calculation & How to Use Them  01 Jun  10 minutes   FeaturedStock Markets  Top Traders in India 31 May  9 minutes   Stock Markets  What are monopoly stocks? Top monopoly stocks in India 30 May  11 minutes   Stock Markets  Hedging – What is it, Types, Strategies, FAQs 29 May  8 minutes   Stock Markets  Put Call Ratio (PCR) – Definition, Formula and Calculation 29 May  7 minutes   Stock Markets  Can stocks make you rich? What are investment options in stock markets?  28 May  7 minutes   Stock Markets  Central Pivot Range – What is it? Calculation, Interpretation & Benefits 28 May  7 minutes   Stock Markets  BSE Sensex: What is it? List of stocks on Sensex, History, Calculation 25 May  6 minutesDownload one of India's best wealth management appsJoin more than one million investors and take control of your wealth Download app         Download the Fisdom app here       Google Play      App store CompanyAbout usPricingCareersBlogFisdom in NewsProductStock / F&OMutual FundIPO & morePension FundsHelp & SupportKnowledge BaseContact usBrokerage CalculatorAdvisory KYC UpdationPoliciesPrivacy PolicyTermsInvestor CharterInvestor ComplaintsDownload FormsDisclaimerRefundScheme Offer DocumentsBank DetailsGlossaryRegulatory DisclosureFollow us:  We are well certified SEBI Registered Investment Advisor INA200005323 BSE Registered Mutual Fund Distributor Code No:10140 IRDAI Corporate Agent Finwizard Technology Pvt Ltd CA License No:
 CA0505
 License Valid till: 19-Jun-2023 256 Bit SSL encryption security Association of Mutual Funds of India Registered Mutual Fund
 Distributor
 ARN:1031682023 Copyright, All Right Reserved, Built for Investors, Pro Traders &
 Beginners withFinwizard Technology Private Limited is a member of National Stock Exchange of India Limited (Member code:90228) & BSE Limited (Member code:6696 ) SEBI Registration No. INZ000209036SEBI Depository Participant Registration No. IN-DP-572-2021Mutual Fund distributor with AMFI Registration No. ARN:103168SEBI Registered Investment Advisor INA200005323Finwizard Technology Private Limited CIN number : U74900KA2015PTC080747SEBI Research Analyst No. INH000010238Registered Office AddressQueens Paradise, No. 16/1, 1st Floor Curve Road, Shivaji Nagar, Bengaluru, Karnataka 560071Correspondence/Communication AddressOffice No.1002, A wing, 10th Floor, Kanakia Wall Street, Hanuman Nagar, Andheri Kurla Road, Chakala, Andheri (East), Mumbai - 400093Tel: +91 96425 96425Compliance Officer Name : Krishna Jakkula; Email ID : compliance@fisdom.com ; +91 89519 49507For any grievances related to stock broking/dp, please write to grievances@fisdom.com,Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBIProcedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievancesDisclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in Vernacular Language: BSE | NSEAttention Investors +Prevent unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.If you are subscribing to an IPO, there is no need to issue a cheque. Please write the Bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non allotment the funds will remain in your bank account.Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w. e. f. September 01, 2020.Update your e-mail and phone number with your stock broker/depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.Check your securities/MF/bonds in the consolidated account statement issued by NSDL/CDSL every month. Investors should be cautious on unsolicited emails and SMS advising to buy or sell securities and trade only on the basis of informed decisions.Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 & vide notice no. BSE 20200731-7 dated July 31, 2020 and BSE 20200831-45 dated August 31, 2020 and other guidelines issued from time to time in this regard.View more information on Investor's Attention“Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 & vide notice no. BSE 20200731-7 dated July 31, 2020 and BSE 20200831-45 dated August 31, 2020 and other guidelines issued from time to time in this regard.”Members are also advised to display the following messages on their respective websites under a separate banner “Advisory for investors”:Attention Investors!Beware of fixed/guaranteed/regular returns/ capital protection schemes. Brokers or their authorized persons or any of their associates are not authorized to offer fixed/guaranteed/regular returns/ capital protection on your investment or authorized to enter into any loan agreement with you to pay interest on the funds offered by you. Please note that in case of default of a member claim for funds or securities given to the broker under any arrangement/ agreement of indicative return will not be accepted by the relevant Committee of the Exchange as per the approved norms.Do not keep funds idle with the Stock Broker. Please note that your stock broker has to return the credit balance lying with them, within three working days in case you have not done any transaction within last 30 calendar days. Please note that in case of default of a Member, claim for funds and securities, without any transaction on the exchange will not be accepted by the relevant Committee of the Exchange as per the approved norms.Check the frequency of accounts settlement opted for. If you have opted for running account, please ensure that your broker settles your account and, in any case, not later than once in 90 days (or 30 days if you have opted for 30 days settlement). In case of declaration of trading member as defaulter, the claims of clients against such defaulter member would be subject to norms for eligibility of claims for compensation from IPF to the clients of the defaulter member. These norms are available on Exchange website at following link:BSE | NSE.Brokers are not permitted to accept transfer of securities as margin. Securities offered as margin/ collateral MUST remain in the account of the client and can be pledged to the broker only by way of ‘margin pledge’, created in the Depository system. Clients are not permitted to place any securities with the broker or associate of the broker or authorized person of the broker for any reason. Broker can take securities belonging to clients only for settlement of securities sold by the client.Always keep your contact details viz. Mobile number/Email ID updated with the stock broker. Email and mobile number is mandatory and you must provide the same to your broker for updation in Exchange records. You must immediately take up the matter with Stock Broker/Exchange if you are not receiving the messages from Exchange/Depositories regularly.Don't ignore any emails/SMSs received from the Exchange for trades done by you. Verify the same with the Contract notes/Statement of accounts received from your broker and report discrepancy, if any, to your broker in writing immediately and if the Stock Broker does not respond, please take this up with the Exchange/Depositories forthwith.Check messages sent by Exchanges on a weekly basis regarding funds and securities balances reported by the trading member, compare it with the weekly statement of account sent by broker and immediately raise a concern to the exchange if you notice a discrepancy.Please do not transfer funds, for the purposes of trading to anyone, including an authorized person or an associate of the broker, other than a SEBI registered Stock broker.”Precautions for clients dealing in OptionsClients/Investors are advised to avoid below-mentioned practices:Sharing of trading credentials – login id & passwords including OTP’s.Trading in leveraged products like options without proper understanding, which could lead tolossesWriting/ selling options or trading in option strategies based on tips, without basic knowledge& understanding of the product and its risksDealing in unsolicited tips through WhatsApp, Telegram, YouTube, Facebook, SMS, calls, etc.Trading in “Options” based on recommendations from unauthorised / unregistered investmentadvisors and influencers.  ​      Close modal                     